Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.93B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.16B |
| 3 |
Albemarle
ALB
|
+$741M |
| 4 |
FRC
First Republic Bank
FRC
|
+$599M |
| 5 |
VICI Properties
VICI
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.16B |
| 2 |
Netflix
NFLX
|
+$1.04B |
| 3 |
Meta Platforms (Facebook)
META
|
+$872M |
| 4 |
EOG Resources
EOG
|
+$800M |
| 5 |
Intercontinental Exchange
ICE
|
+$700M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.46% |
| 2 | Healthcare | 16.89% |
| 3 | Financials | 14.17% |
| 4 | Communication Services | 10.18% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sweetgreen
SG
$700M
| $3.4M | ﹤0.01% |
291,701
-108,299
| -27% | -$2.28M |
|
|
CLLS
427
Cellectis
CLLS
$313M
| $1.64M | ﹤0.01% |
581,037
-1,011,017
| -64% | -$3.56M |
|
428
Vanguard FTSE All-World ex-US ETF
VEU
$70.8B
| $1.25M | ﹤0.01% |
24,955
+13,992
| +128% | +$749K |
|
429
Sana Biotechnology
SANA
$1.11B
| $1.16M | ﹤0.01% |
179,600
-1,019,705
| -85% | -$6.5M |
|
|
GRFS
430
Grifois
GRFS
$5.41B
| $747K | ﹤0.01% |
66,100
-661,136
| -91% | -$7.89M |
|
431
Momentus Inc Warrant
MNTSW
| $619K | ﹤0.01% |
2,225,000
| – | – |
|
432
iShares Global 100 ETF
IOO
$9.48B
| $561K | ﹤0.01% |
8,641
+5,216
| +152% | +$362K |
|
433
iShares Russell 1000 ETF
IWB
$50.5B
| $447K | ﹤0.01% |
2,131
-5,363
| -72% | -$1.21M |
|
|
SAND
434
DELISTED
Sandstorm Gold
SAND
| $225K | ﹤0.01% |
37,869
-3,646,882
| -99% | -$25.9M |
|
435
PagSeguro Digital
PAGS
$2.44B
| $206K | ﹤0.01% |
20,146
-73,602
| -79% | -$1.05M |
|
|
AZUL
436
DELISTED
Azul
AZUL
| $164K | ﹤0.01% |
23,035
| – | – |
|
437
AbCellera Biologics
ABCL
$3.25B
| – | – |
-2,626,644
| Closed | -$25.6M |
|
|
ADAG
438
Adagene
ADAG
$249M
| – | – |
-1,112,200
| Closed | -$3.97M |
|
439
Advanced Energy
AEIS
$13.5B
| – | – |
-261,162
| Closed | -$22.5M |
|
440
BHP
BHP
$226B
| – | – |
-198,067
| Closed | -$13.8M |
|
441
Blend Labs
BLND
$357M
| – | – |
-2,330,432
| Closed | -$13.3M |
|
442
Canadian National Railway
CNI
$77.1B
| – | – |
-25,462
| Closed | -$3.4M |
|
443
Fair Isaac
FICO
$23B
| – | – |
-29,100
| Closed | -$13.6M |
|
444
Fortis
FTS
$28.8B
| – | – |
-6,560
| Closed | -$324K |
|
445
Grab
GRAB
$14.8B
| – | – |
-19,097,374
| Closed | -$66.8M |
|
446
Hamilton Lane
HLNE
$5.75B
| – | – |
-442,970
| Closed | -$34.2M |
|
447
Kornit Digital
KRNT
$852M
| – | – |
-708,916
| Closed | -$58.6M |
|
448
Kratos Defense & Security Solutions
KTOS
$11.9B
| – | – |
-2,918,231
| Closed | -$59.8M |
|
449
Live Oak Bancshares
LOB
$2B
| – | – |
-400,900
| Closed | -$20.4M |
|
450
Marriott International
MAR
$92.5B
| – | – |
-2,044,444
| Closed | -$359M |
|
Similar funds
Capital International Investors's Q2 2022 Portfolio in Review
As of Q2 2022, Capital International Investors held 470 positions worth $368B, down 16% from $439B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital International Investors's Q2 2022 filing shows 16 new, 197 increased, 171 reduced and 33 closed positions. Its largest new stake was Albemarle: 3,322,014 shares worth $694M. The largest sale was Eli Lilly, an estimated $1.16B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Capital International Investors's largest Q2 2022 buy was Albemarle: 3,322,014 shares worth $694M.
- Capital International Investors added most to AbbVie in Q2 2022, an estimated $1.93B increase.
- Capital International Investors's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $1.16B.
- Capital International Investors fully exited Marriott International in Q2 2022, selling an estimated $359M.
- Capital International Investors's ten largest holdings make up 27% of its $368B portfolio in Q2 2022.
- Capital International Investors opened 16 new positions and closed 33 in Q2 2022.
- Capital International Investors's portfolio value fell 16% quarter-over-quarter to $368B.
Based on Capital International Investors's 13F filing for Q2 2022, filed 15 Aug 2022.